Fundz

Cytosolix reported raising $6.61 Million in an initial SEC Form D filing, from an offering of $6.61 Million

PRIVATEJun 28, 2023

Amount Raised

$6.61 Million

$6.61 Million sold, per SEC Form D (first sale Jun 12, 2023)

Round Type

Venture

TollandBiotechnology

Quick answer

Cytosolix raised $6.61 Million in a funding round, dated June 12, 2023. Cytosolix is based in Tolland, Connecticut, United States.

How much did Cytosolix raise?
Cytosolix raised $6.61 Million in a funding round on June 12, 2023.
What does Cytosolix do?
Cytosolix is a private, early stage life sciences company spun out of Yale University, developing novel oral & IV derivatives of known small molecule oncology drugs that selectively target cancer cells via a universal..
Where is Cytosolix based and how big is it?
Cytosolix is based in Tolland, Connecticut, United States.
Who are the decision-makers at Cytosolix?
Fundz holds 1 contact at Cytosolix. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Cytosolix that raised within 45 days of this round, from Fundz verified event records.

  • Quadrant Biosciences Inc raised $3.5M (Seed) on July 27, 2023.
  • Better Therapeutics raised $2.1M (Seed) on July 27, 2023.
  • Octave Bioscience raised an undisclosed amount (Funding Round) on July 26, 2023.
  • Kriya Therapeutics raised an undisclosed amount (Series C) on July 26, 2023.
  • Nexo Therapeutics raised $60M (Series A) on July 26, 2023.
  • Octave Bioscience raised $30M (Series B) on July 26, 2023.

Who to call at Cytosolix, and when

A new round usually means Cytosolix is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cytosolix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cytosolix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cytosolix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cytosolix

Location

97 ROBBIE ROAD

Tolland, Connecticut, United States

About

Cytosolix is a private, early stage life sciences company spun out of Yale University, developing novel oral & IV derivatives of known small molecule oncology drugs that selectively target cancer cells via a universal biomarker of solid tumors - acidity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cytosolix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Cytosolix's next move

See what Strategic adds

Cytosolix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.